Skip to content
Saturday, March 15, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
5
Biosimilars drive Sandoz growth ahead of unclear tariff effects in 2025
GLP-1 News
Biosimilars drive Sandoz growth ahead of unclear tariff effects in 2025
March 5, 2025
admin
Sales in Sandoz’s biosimilar business grew 30% buoyed by US launches including Humira-biosimilar.
Post navigation
Novo Nordisk Joins Legal Battle Over Weight Loss Drug Shortage – Bloomberg Law
Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales – MedCity News